Re: TD Zenith Capital Corp | Grey Market : ZHCLF
in response to
by
posted on
Jul 14, 2020 04:10PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
& this board has it as ZZXY & under the OTCCB?
Zenith Epigenetics